October 19, 2023, a Quick Reality Check for us ALL:
Here are some Basic Comparables and background research used for Cancer Drug valuations. Some of these...October 19, 2023, a Quick Reality Check for us ALL:
Here are some Basic Comparables and background research used for Cancer Drug valuations. Some of these links I've shared with you Guys before.
Some of this info is much more in-depth per dollar invested ratio to returns and time frame for average investment recoup. No WONDER why the BAR is so High for these Cancer Killing Drugs, they are ALL BlockBuster Drugs.
Good thing we are already OVER the Bar, your investments are about to change Folks, from Dreams to Reality:
www.reuters.com/business/healthcare-pharmaceutical…
www.fiercepharma.com/special-report/special-report…
www.spglobal.com/marketintelligence/en/news-insigh…
jamanetwork.com/journals/jamanetworkopen/fullartic…
ascopubs.org/doi/full/10.1200/EDBK_200867
Things that make you GO hmmmmm
All the Best Guys!
More Progress News coming.
Thanks again for your Support Over ALL THESE YEARS !!!
Talk soon.
Raymond - IGWT
Show more
UPDATE: December 1, 2023:
GBXI, FINAL 4th & GOAL Close-out
CSi-Loyalty GIFT Shares & CSi-VIP Investments Close-out
GBXI, FINAL PUSH
Over the Finish line!
UNDERWAY Now!
*** Click here for the FINAL 4th & Goal REPORT !!
Thank God, we just received POSITIVE communications from the OTC Exchange on their final GBXI review. So please review some of our previous “QUOTES & Images ” from our Greatest moments before we begin trading again. Please click the FINAL Report Link for the December 1, 2023 Final 4th & GOAL Report. Once (OTC: GBXI) begins trading again ALL the Share Issuances will resume and ALL Promotions will end.
Let’s raise the money we need NOW and have ALL our Shareholders become VIP’s!
We will be giving ALL our VIP's access to all our Events and Promotions. ALL your Investments help PUSH us over the Finish Line, Right NOW!
*** Click here for the FINAL 4th & Goal REPORT !!
*** Any Shareholder questions. Please contact Robert asap:
Mr. Robert Kane,
Member Board of Directors
Director of Investor Relations
GBX International Group Inc., OTC: (GBXI)
American States University
Cannabis Science
Thermic Science (ENDO)
C. (910) 515-2917
robert.kane@americanstatesuniversity.com
May 11, 2023, GBX International Group, Inc., (OTC: GBXI)
GBX International Group, Inc. (OTC:GBXI) Confirms 2023 Strong Revenue Growth Guidance Projections by Combining Each Acquired Operating Company Product Release, Expects Strong Growth Sector by Sector Through its Multiple Product Releases into North American and International Markets
April 21, 2023, GBX International Group, Inc., (OTC: GBXI)
HARVARD Award Winning Entrepreneur, Mr. Raymond C. Dabney Acquires Majority Shareholder Control of GBX International Group, Inc. (OTC: GBXI) Makes More History Bringing CSi-EDP Partner American States University (ASU) as the First Acquisition for its Aggressive Growth Plans
The ASU Digital Business HUB will be used as the main business student learning center. GBXI will be the main pivot point to spin out trading shares of all our Partner Public and Private Companies such as Cannabis Science, iCannabinoid, Thermic Science, LNC, LMG, and a few more old and new school surprises for our loyal shareholders. No one will be missed! A true Digital Business HUB for students, just as planned all along.
Each spinout company will give our GBXI registered shareholders additional pro-rata shares in each spinout company over and above their original shares in each entity. This provides the required shareholder base for each company required to trade and gives additional shares to all our loyal GBXI shareholders.
We call this “Compounding our Wealth” through extra spinout share participation for all our loyal GBXI shareholders. Each registered GBXI shareholder will receive additional shares of each spinout Company over and above their original shares to enjoy additional liquidity as each company begins to trade through the GBXI Digital Business HUB spinout process.
Click here to review the Report:
Case No. 2:17-CV-02271-KJM-JDP
Inspire, Dream, Change
YOUR DIGITAL ERA Personal & Business Access Learning HUB
October 19, 2023, a Quick Reality Check for us ALL:
Here are some Basic Comparables and background research used for Cancer Drug valuations. Some of these...October 19, 2023, a Quick Reality Check for us ALL:
Here are some Basic Comparables and background research used for Cancer Drug valuations. Some of these links I've shared with you Guys before.
Some of this info is much more in-depth per dollar invested ratio to returns and time frame for average investment recoup. No WONDER why the BAR is so High for these Cancer Killing Drugs, they are ALL BlockBuster Drugs.
Good thing we are already OVER the Bar, your investments are about to change Folks, from Dreams to Reality:
www.reuters.com/business/healthcare-pharmaceutical…
www.fiercepharma.com/special-report/special-report…
www.spglobal.com/marketintelligence/en/news-insigh…
jamanetwork.com/journals/jamanetworkopen/fullartic…
ascopubs.org/doi/full/10.1200/EDBK_200867
Things that make you GO hmmmmm
All the Best Guys!
More Progress News coming.
Thanks again for your Support Over ALL THESE YEARS !!!
Talk soon.
Raymond - IGWT
Show more
Cannabis Science CEO, Presents …
The FINAL “CBIS GIFT Shares” Issuances!
DECEMBER 1, 2022, Cheers! & HAPPY HOLIDAYS !!!
ALL GIFT Shares 1, 2, & 3 being ISSUED !!!
LAST Steps:
Please confirm Yours NOW !!!
1. CONFIRM Correct Total Share Amount(s)
2. CONFIRM Correct Name(s) on CERTIFICATE
3. CONFIRM Correct Mailing Address
ASU/CSi-EDP-ECO-System
At it's FINEST !!!
WHICH ONE ARE YOU ??
Those who, MAKE things happen.
Those who WATCH things happen.
Those who WONDER what the ... HAPPENED ???
We can make this HAPPEN way FASTER Working as a TEAM !!!
WHAT Matters is how much you CARE about KILLING CANCERS ...
This is it ... We are ALL Here ... Now ... with a Bunch of Celebrities going on TV Worldwide to Start raising $20 Million to Keep Killing Cancers.
2023 Audit considerations NASDAQ.
Cannabis Science Inc.
Share Structure 2023
Par Value: $0.001 USD
Last Price: $0.00647 USD
OTC Markets.
Common Stock:
Authorized:
5,000,000,000
Issued:
2,521,095,296
Class A Common Stock
Authorized:
100,000,000
Issued:
0
Class B Common Stock
Authorized:
1,500,000,000
Issued:
0
Preferred Stock
Authorized:
1,000,000
Issued:
1,000,000
Sign up for a FREE Assessment to JOIN the UNIVERSITY Team or any ASU/CSi-EDP Team for whatever your AREA of Expertise is … then say no more… you already know.
You already know our Extensive LIST of GROUNDBREAKING Products.
1-Million STRONG TV Coverage, HARVARD Award Success.
TAKE YOUR PICK AND BECOME A PART OF HISTORICAL CHANGE
*** APPLY for FREE in CONFIDENCE and Success.
Each Product launch WE RELEASE will include Equity Participation according to standard salaries and share bonus structures.
EVERYONE sign up to add your STRENGTHS to OUR COMBINED SUCCESS and lets MAKE THIS HAPPEN NOW !!!